AI assistant
Sending…
Centessa Pharmaceuticals plc — Director's Dealing 2022
Jul 7, 2022
31309_dirs_2022-07-06_cc93d0cb-4652-46e6-9882-73b29c59e9f1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Centessa Pharmaceuticals plc (CNTA)
CIK: 0001847903
Period of Report: 2022-07-01
Reporting Person: Hukkelhoven Mathias (Director)
More from Centessa Pharmaceuticals plc
M&A Activity
2026
May 22
Annual Report
2026
Apr 29
Proxy Solicitation & Information Statement
2026
Apr 29
Share Issue/Capital Change
2026
Mar 31
M&A Activity
2026
Mar 31
Proxy Solicitation & Information Statement
2026
Mar 31
Director's Dealing
2026
Mar 27
Director's Dealing
2026
Mar 27
Regulatory Filings
2026
Mar 26
Director's Dealing
2026
Mar 18